{
  "Q0": "BRCA1/BRCA2 genetic testing",
  "Q1": "Yes",
  "Q2": "Not specified",
  "Q3": "No",
  "Q4": "Yes",
  "Q4-1": "Yes",
  "Q4-2": "NCCN",
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "No",
  "Q8": "No",
  "Q9": "Yes",
  "Q9-1": "No",
  "Q10": "No",
  "Q10-1": "Diagnostic",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Yes",
  "Q14-1": "81162, 81163, 81164, 81165, 81166, 81167, 81212, 81215, 81216, 81217",
  "Q15": "No",
  "Q16": "No",
  "Q17": "According to the policy, genetic testing should be performed in a setting with suitably trained healthcare providers who can give appropriate pre- and post-test counseling and that has access to a CLIA-licensed laboratory. Since the patient does not meet medical necessity criteria, the test would not be covered. If the provider believes testing is still warranted, they would need to document why the patient might have >5% probability of a BRCA1/2 variant based on risk models like Tyrer-Cuzick or BRCAPro.",
  "match": false
}